Direct-to-consumer genetic testing summary of a workshop

"Today, scores of companies, primarily in the United States and Europe, are offering whole genome scanning services directly to the public. The proliferation of these companies and the services they offer demonstrate a public appetite for this information and where the future of genetics may be...

Descripción completa

Detalles Bibliográficos
Autor principal: Institute of Medicine (U.S.) (-)
Autores Corporativos: Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation, National Research Council (U.S.), National Research Council (U.S.). Committee on Science, Technology, and Law, National Research Council (U.S.). Board on Life Sciences, National Research Council (U.S.). Division on Earth and Life Studies, Institute of Medicine (U.S.). Board on Health Sciences Policy, Institute of Medicine (U.S.). Roundtable on Translating Genomic-Based Research for Health, National Cancer Policy Forum (U.S.), Institute of Medicine (U.S.). Board on Health Care Services
Otros Autores: Fraker, Mary (-), Mazza, Anne-Marie
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press 2010.
Edición:1st ed
Materias:
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009622271406719
Tabla de Contenidos:
  • Introduction
  • Scientific foundations for direct-to-consumer genetic testing
  • Personal and social issues
  • Research and medical issues
  • Impact on health care and public health
  • Current legislative and regulatory framework in the United States
  • Areas for further study.